Skip to main content

MINI REVIEW article

Front. Oncol.

Sec. Molecular and Cellular Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1521988

CENP-H as a new diagnostic and prognostic biomarker for tumors: A real-world literature review

Provisionally accepted
Qiao Li Qiao Li *Yang Tang Yang Tang Jie-Bin Zuo Jie-Bin Zuo Hao Han Hao Han Guang-Xu Tu Guang-Xu Tu Cheng Chen Cheng Chen *
  • Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China

The final, formatted version of the article will be published soon.

    Centromere protein H (CENP-H) is an important component of a functional centromere. Studies have demonstrated that CENP-H is overexpressed in renal cell, gastric, hypopharyngeal squamous cell, nasopharyngeal, endometrial, lung, cervical, esophageal, liver, colorectal, oral squamous cell, breast, and tongue carcinomas. CENP-H overexpression is positively correlated with a poor prognosis, pathological stage, tumor (T) stage, and lymph node metastasis in patients with the above carcinomas. CENP-H can promote cancer growth and metastasis through PI3K/ AKT, survivin, and mitochondrial apoptosis signaling mechanisms, and it can be regulated by long non-coding ribonucleic acid (lncRNA) plasmacytoma variant translocation 1 (PVT1)/miR-612, Sp1, or Sp3. This review aims to summarize the expression of CENP-H, the relationship between CENP-H expression and prognostic features, growth and metastasis of cancer in patients, as well as the mechanism of CENP-H in cancer. It also proposes a new candidate molecule for treating patients with cancer.

    Keywords: CENP-H, Cancer, Poor prognosis, biomarker, lncRNA

    Received: 03 Nov 2024; Accepted: 07 Feb 2025.

    Copyright: © 2025 Li, Tang, Zuo, Han, Tu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Qiao Li, Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China
    Cheng Chen, Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more